Leventa 1 mg/ml oral solution for dogs
Leventa 1 mg/ml oral solution for dogs
Authorised
- Levothyroxine sodium
Product identification
Medicine name:
Leventa 1 mg/ml oral solution for dogs
Leventa 1 mg/ml Drank
Leventa 1 mg/ml Solution buvable
Leventa 1 mg/ml Lösung zum Einnehmen
Active substance:
- Levothyroxine sodium
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Levothyroxine sodium1.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QH03AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proofclosure in a printed carton.A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product.Pack size: 1 x 30 ml
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proofclosure in a printed carton.A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product.Pack size: 6 x 30 ml
- 30 mL amber glass bottle with a transparent LDPE insert and with a white HDPE child-resistant cap with tamper-proofclosure in a printed carton.A 1 ml oral syringe graduated in 0.05 ml increments is supplied with the product.Pack size: 12 x 30 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet Productions S.A.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V303606
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0182/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 1/06/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
